Goudarzi, Ramin
Amini, Sima
Dehpour, Ahmad Reza
Partoazar, Alireza
Article History
Received: 24 October 2018
Accepted: 1 June 2019
First Online: 24 June 2019
Compliance with Ethical Standards
:
: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the article. Dr. Ramin Goudarzi owns equity in Pharmin USA which manufactures and distributes Arthrocen.